Pandemic Influenza

News Pandemic Influenza

• European Medicines Agency reviews hypothesis on Pandemrix and development of narcolepsy

  The European Medicines Agency's Committee on Human Medicinal Products (CHMP) at the request of the Agency’s Executive Director Guido Rasi has reviewed preliminary research results by the Finnish National Institute of Health and Welfare (THL) investigating differences in the immunological response tr more

• Intercell announces Phase I results on its Vaccine Enhancement Patch (VEP) with Pandemic Influenza antigens

  Intercell AG announced the results from a Phase I study investigating Intercell's adjuvant patch (Vaccine Enhancement Patch - VEP) containing LT (a heat-labile toxin from E. coli) in combination with an IM administration of an A/H5N1 antigen supplied by GSK.This trial follows earlier Phase I and Pha more

• Swine flu present in many ‘healthy’ farm-show pigs

  Despite their healthy appearance, several pigs on show at a 2009 U.S. state fair competition were infected with swine flu, according to a new study by University of Florida infectious disease experts. Up to 20 percent of show pigs at the 2009 Minnesota state fair were infected, and an infected anima more

Publications Pandemic Influenza

• Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China

  Background Laboratory‐confirmed deaths grossly underestimate influenza mortality burden, so that reliable burden estimates are derived from indirect statistical studies, which are scarce in low‐ and middle‐income settings. Objectives Here, we used statistical excess mortality models to es more

• Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009–2010 in Spain

  Background The present report compares prognosis in hospitalized cases with the H1N1 pandemic virus in two seasons. Methods Two series of hospitalized patients with laboratory‐confirmed H1N1 pandemic influenza have been compared: 813 in the season 2009–2010 and 707 in the season 2010–2011 more

• A statistical strategy to identify recombinant viral ribonucleoprotein of avian, human, and swine influenza A viruses with elevated polymerase activity

  Objectives Reassortment of influenza A viruses can give rise to viral ribonucleoproteins (vRNPs) with elevated polymerase activity and the previous three pandemic influenza viruses contained reassorted vRNPs of different origins. These suggest that reassorted vRNP may be one of the factors leadi more

Market studies Pandemic Influenza

• IntelligentMDx - Strategic SWOT Analysis Review

  IntelligentMDx (IMDx) is a molecular diagnostics company, engaged in the design, development and marketing of molecular diagnostic test solutions. The company's product offerings includes a broad range of Compliant RUOs (cRUO) and IVD Products in the a Healthcare-Associated Infections, Respiratory T more

• NasVax Ltd. (NSVX) - Financial and Strategic SWOT Analysis Review

  NasVax Ltd. (NasVax) is bio-pharmaceutical company, principally engaged in developing advanced vaccines and immunotherapeutics. It focuses on improving the effectiveness or administration of vaccines based on its VaxiSome technology platform. This technology enables the company to create adjuvant ag more

• Sinovac Biotech Ltd. (SVA) - Financial and Strategic SWOT Analysis Review

  Sinovac Biotech Ltd is engaged in the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. Sinovac was the first company worldwide to recei more

Websites Pandemic Influenza